| Basics |
|
Whitehawk Therapeutics, Inc
|
| IPO Date: |
February 12, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$85.77M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.26 | 2.98%
|
| Avg Daily Range (30 D): |
$0.04 | 2.04%
|
| Avg Daily Range (90 D): |
$0.05 | 2.80%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.16M |
| Avg Daily Volume (30 D): |
.08M |
| Avg Daily Volume (90 D): |
.11M |
| Trade Size |
| Avg Trade Size (Sh.): |
112 |
| Avg Trade Size (Sh.) (30 D): |
217 |
| Avg Trade Size (Sh.) (90 D): |
237 |
| Institutional Trades |
| Total Inst.Trades: |
78 |
| Avg Inst. Trade: |
$1.76M |
| Avg Inst. Trade (30 D): |
$1.41M |
| Avg Inst. Trade (90 D): |
$1.5M |
| Avg Inst. Trade Volume: |
.19M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.58M |
| Avg Closing Trade (30 D): |
$1.41M |
| Avg Closing Trade (90 D): |
$1.41M |
| Avg Closing Volume: |
401.57K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
N/A |
|
Basic EPS
|
$-.76
|
$1.84
|
|
|
Diluted EPS
|
$-.76
|
$1.83
|
|
|
Revenue
|
$ M
|
$ 7.15M
|
$
|
|
Gross Profit
|
$ M
|
$ 6.39M
|
$
|
|
Net Income / Loss
|
$ -52.62M
|
$ 73.02M
|
$
|
|
Operating Income / Loss
|
$ -54.75M
|
$ -15.22M
|
$
|
|
Cost of Revenue
|
$ M
|
$ .76M
|
$
|
|
Net Cash Flow
|
$ -82.63M
|
$ 198.84M
|
$
|
|
PE Ratio
|
|
|
|
| Splits |
|
Aug 27, 2021:
1:15
|
|
Dec 18, 2007:
4.50:1
|
|
Aug 31, 2005:
5:4
|
|
|
|
